(TDY) Teledyne Technologies - Overview
Stock: Sensors, Cameras, Instrumentation, Avionics,
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 22.1% |
| Relative Tail Risk | -8.38% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.89 |
| Alpha | 11.83 |
| Character TTM | |
|---|---|
| Beta | 0.788 |
| Beta Downside | 0.943 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.97% |
| CAGR/Max DD | 0.72 |
Description: TDY Teledyne Technologies December 17, 2025
Teledyne Technologies (TDY) delivers a diversified portfolio of high-performance technologies across four primary segments: Digital Imaging, Instrumentation, Aerospace & Defense Electronics, and Engineered Systems, serving industrial, defense, space, and energy markets worldwide.
The Digital Imaging segment produces visible-spectrum sensors, infrared and X-ray cameras, MEMS devices, and related optics, supporting applications from autonomous vehicles to CBRNE detection. The Instrumentation segment supplies test-and-measurement gear, power and communications connectivity for distributed sensor networks. Aerospace & Defense Electronics offers rugged components, avionics, and data-link solutions for both aircraft and ground platforms. Engineered Systems provides systems integration, electrochemical energy solutions, and defense-grade electronics.
Key recent metrics: FY 2023 revenue of approximately $2.1 billion, with an operating margin near 13 %; the Digital Imaging segment grew ~9 % YoY, driven by rising demand for infrared sensors in autonomous-driving and defense applications. Defense spending in the U.S. and Europe is expected to rise 4-5 % annually through 2028, underpinning long-term demand for TDY’s aerospace and engineered-systems offerings.
Investors should watch semiconductor supply-chain dynamics and the pace of defense budget allocations, as both factors materially affect TDY’s ability to meet order backlogs and sustain margin expansion.
For a deeper quantitative view, the ValueRay platform offers a granular breakdown of TDY’s valuation metrics.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 894.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.78 > 1.0 |
| NWC/Revenue: 19.55% < 20% (prev 29.68%; Δ -10.13% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.19b > Net Income 894.8m |
| Net Debt (2.12b) to EBITDA (1.49b): 1.42 < 3 |
| Current Ratio: 1.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.2m) vs 12m ago -0.84% < -2% |
| Gross Margin: 39.22% > 18% (prev 0.43%; Δ 3879 % > 0.5%) |
| Asset Turnover: 41.48% > 50% (prev 39.93%; Δ 1.55% > 0%) |
| Interest Coverage Ratio: 19.40 > 6 (EBITDA TTM 1.49b / Interest Expense TTM 59.6m) |
Altman Z'' 4.78
| A: 0.08 (Total Current Assets 3.06b - Total Current Liabilities 1.86b) / Total Assets 15.29b |
| B: 0.44 (Retained Earnings 6.67b / Total Assets 15.29b) |
| C: 0.08 (EBIT TTM 1.16b / Avg Total Assets 14.74b) |
| D: 2.20 (Book Value of Equity 10.51b / Total Liabilities 4.77b) |
| Altman-Z'' Score: 4.78 = AA |
Beneish M -2.86
| DSRI: 1.04 (Receivables 1.37b/1.21b, Revenue 6.12b/5.67b) |
| GMI: 1.10 (GM 39.22% / 42.94%) |
| AQI: 1.01 (AQ_t 0.75 / AQ_t-1 0.74) |
| SGI: 1.08 (Revenue 6.12b / 5.67b) |
| TATA: -0.02 (NI 894.8m - CFO 1.19b) / TA 15.29b) |
| Beneish M-Score: -2.86 (Cap -4..+1) = A |
What is the price of TDY shares?
Over the past week, the price has changed by +3.96%, over one month by +22.20%, over three months by +23.56% and over the past year by +26.19%.
Is TDY a buy, sell or hold?
- StrongBuy: 6
- Buy: 4
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TDY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 668.9 | 4.4% |
| Analysts Target Price | 668.9 | 4.4% |
| ValueRay Target Price | 695.9 | 8.7% |
TDY Fundamental Data Overview February 01, 2026
P/E Forward = 25.974
P/S = 4.7624
P/B = 2.7924
P/EG = 0.98
Revenue TTM = 6.12b USD
EBIT TTM = 1.16b USD
EBITDA TTM = 1.49b USD
Long Term Debt = 2.03b USD (from longTermDebt, last quarter)
Short Term Debt = 450.1m USD (from shortTermDebt, last quarter)
Debt = 2.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.12b USD (from netDebt column, last quarter)
Enterprise Value = 31.25b USD (29.12b + Debt 2.48b - CCE 352.4m)
Interest Coverage Ratio = 19.40 (Ebit TTM 1.16b / Interest Expense TTM 59.6m)
EV/FCF = 29.09x (Enterprise Value 31.25b / FCF TTM 1.07b)
FCF Yield = 3.44% (FCF TTM 1.07b / Enterprise Value 31.25b)
FCF Margin = 17.56% (FCF TTM 1.07b / Revenue TTM 6.12b)
Net Margin = 14.63% (Net Income TTM 894.8m / Revenue TTM 6.12b)
Gross Margin = 39.22% ((Revenue TTM 6.12b - Cost of Revenue TTM 3.72b) / Revenue TTM)
Gross Margin QoQ = 29.44% (prev 42.84%)
Tobins Q-Ratio = 2.04 (Enterprise Value 31.25b / Total Assets 15.29b)
Interest Expense / Debt = 0.49% (Interest Expense 12.1m / Debt 2.48b)
Taxrate = 14.20% (45.6m / 321.2m)
NOPAT = 992.0m (EBIT 1.16b * (1 - 14.20%))
Current Ratio = 1.64 (Total Current Assets 3.06b / Total Current Liabilities 1.86b)
Debt / Equity = 0.24 (Debt 2.48b / totalStockholderEquity, last quarter 10.51b)
Debt / EBITDA = 1.42 (Net Debt 2.12b / EBITDA 1.49b)
Debt / FCF = 1.98 (Net Debt 2.12b / FCF TTM 1.07b)
Total Stockholder Equity = 10.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.07% (Net Income 894.8m / Total Assets 15.29b)
RoE = 8.65% (Net Income TTM 894.8m / Total Stockholder Equity 10.34b)
RoCE = 9.35% (EBIT 1.16b / Capital Employed (Equity 10.34b + L.T.Debt 2.03b))
RoIC = 7.63% (NOPAT 992.0m / Invested Capital 12.99b)
WACC = 8.16% (E(29.12b)/V(31.60b) * Re(8.82%) + D(2.48b)/V(31.60b) * Rd(0.49%) * (1-Tc(0.14)))
Discount Rate = 8.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.73%
[DCF Debug] Terminal Value 80.69% ; FCFF base≈1.09b ; Y1≈1.34b ; Y5≈2.26b
Fair Price DCF = 743.2 (EV 37.02b - Net Debt 2.12b = Equity 34.89b / Shares 47.0m; r=8.16% [WACC]; 5y FCF grow 24.57% → 2.90% )
EPS Correlation: 78.95 | EPS CAGR: 8.71% | SUE: 4.0 | # QB: 1
Revenue Correlation: 84.64 | Revenue CAGR: 5.46% | SUE: 1.27 | # QB: 1
EPS next Quarter (2026-03-31): EPS=5.48 | Chg30d=+0.034 | Revisions Net=+2 | Analysts=10
EPS current Year (2026-12-31): EPS=23.80 | Chg30d=+0.148 | Revisions Net=+3 | Growth EPS=+8.2% | Growth Revenue=+4.6%
EPS next Year (2027-12-31): EPS=25.73 | Chg30d=+0.264 | Revisions Net=+3 | Growth EPS=+8.1% | Growth Revenue=+5.0%